Tag: #atrialfibrillation

Sham-controlled trial finds pulmonary vein isolation no better than sham for atrial fibrillation quality of life at six months

A multicentre sham-controlled trial in Europe published in The Lancet found PVI didn’t improve AF-related quality of life versus sham at six months.

#atrialfibrillation, #catheterablation, #cardiology, #clinicaltrials

One-month dual antithrombotic strategy after PCI reduced bleeding without higher 12‑month thromboembolic risk in OPTIMA‑AF trial

OPTIMA‑AF found that stopping dual antithrombotic therapy after one month and continuing a DOAC alone reduced bleeding without raising 12‑month death or thromboembolism.

#cardiology, #atrialfibrillation, #pci, #anticoagulation